| |||
Interactome Yields Data, But Is It Significant?An investment of $100 million should be enough to correlate the genome with function, and identify new basic research and drug targets The first human interactome maps, published just last year, offer literally thousands of starting points for further research.1,2 Yet subsequent analyses also demonstrate just how difficult it can be to convert interaction data into reliable hypotheses. Both Marc Vidal and Erich Wanker, who published his map first, used their data to identify novel interactions. For example, Wanker identified new partners for the protein emerin, a mutation that leads to Emery-Dreifuss muscular dystrophy, as well as novel modulators of the... |
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
